🇺🇸 FDA
Patent

US 11254746

Anti-PD-1 monoclonal antibody, and preparation method therefor and application thereof

granted A61KA61K2039/505A61P

Quick answer

US patent 11254746 (Anti-PD-1 monoclonal antibody, and preparation method therefor and application thereof) held by SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD. expires Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
SUNSHINE GUOJIAN PHARMACEUTICAL (SHANGHAI) CO., LTD.
Grant date
Tue Feb 22 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Feb 17 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
23
CPC classes
A61K, A61K2039/505, A61P, A61P31/00, A61P35/00